16.04.2014 Views

efsa-opinion-chromium-food-drinking-water

efsa-opinion-chromium-food-drinking-water

efsa-opinion-chromium-food-drinking-water

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chromium in <strong>food</strong> and bottled <strong>water</strong><br />

Table H6: Developmental and reproductive toxicity studies with Cr(VI) compounds (continued)<br />

Study* NOAEL LOAEL Effect Reference<br />

Pregnant BALB/c mice<br />

Oral (<strong>drinking</strong> <strong>water</strong>)<br />

0 or 1000 mg potassium dichromate/L<br />

Doses: 0 and 76 mg Cr(VI)/kg b.w. per<br />

day (c)<br />

GD 12- lactation D 20<br />

litters culled to 8 pups/litter on first day<br />

from PND 20: examination for vaginal<br />

opening<br />

PND 60: F caged with untreated M, mating<br />

for 10 days<br />

Sacrifice F 1 wk after mating period for<br />

examination of uterine contents<br />

Additional animals sacrificed on PND 50<br />

Gestational exposure<br />

Pregnant Wistar rats<br />

Oral (<strong>drinking</strong> <strong>water</strong>)<br />

0, 50 mg/L potassium chromate GD 6-15<br />

Doses: 0 and 1.6 mg Cr (VI)/kg b.w. per<br />

day (b)<br />

- 1000 mg/L<br />

76 mg<br />

Cr(VI)/kg<br />

b.w. per day<br />

Maternal &<br />

Developmental<br />

toxicity: -<br />

No effect on b.w. of F offsprings.<br />

Delayed time vaginal opening (delay in onset of puberty) by about<br />

3 days.<br />

Reduction pregnancy rate, number of implantations, viable fetuses<br />

3 resorptions among treated F (none in C).<br />

On PND 50: no effect on b.w., ovarian weight or uterine weight.<br />

Developmental toxicity<br />

Maternal &<br />

Developmental<br />

toxicity:<br />

50 mg/L<br />

1.6 mg Cr<br />

(VI)/kg b.w.<br />

per day<br />

Dams:<br />

Decrease b.w. gain mainly attributed to retarded fetal growth and<br />

resorptions<br />

Histopathological lesions in placenta.<br />

Litters:<br />

Increase number of pre- and post-implantation loss, resorption<br />

frequency and frequency dead fetuses/litter.<br />

Fetuses:<br />

Decrease number live fetuses/litter, fetal weight.<br />

Increase frequencies of visceral and skeletal anomalies, in particular<br />

renal pelvis dilatation and incomplete ossification of skull bones.<br />

Chromium passed placental barrier and accumulated in fetal tissues.<br />

Signif. increase <strong>chromium</strong> levels in blood, placenta and fetal tissues.<br />

Al-Hamood et<br />

al. (1998)<br />

Elsaieed and<br />

Nada (2002)<br />

EFSA Journal 2014;12(3):3595 211

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!